ALNY — Alnylam Pharmaceuticals, Inc.

Healthcare · Biotechnology · NASDAQ

$240.66

Market Cap: $32.2B

Key Fundamentals

P/E Ratio

101.7

P/B Ratio

40.3

Return on Equity

90.3%

Net Profit Margin

8.4%

Revenue Growth

65.2%

Dividend Yield

0.0%

Debt / Equity

1.6

EPS (TTM)

$2.37

Piotroski F-Score

9/9

Beta

0.38

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. (ticker: ALNY, listed on NASDAQ) is a company in the Healthcare · Biotechnology sector with a market capitalization of $32.2B.

This page shows publicly available fundamental data for ALNY sourced from Valory's database of 36,000+ US stocks. For deeper analysis — including Valory Formula projected returns, historical financials, and analyst consensus — create a free account.

Data is updated regularly during US market hours. Fundamental data is sourced from public filings and market data providers. This page is for informational purposes only and does not constitute investment advice.